Payers Should Not Restrict Total Knee Replacement Surgery, Study Finds Cost Effective

by Elizabeth Krutoholow

Total knee replacement surgery is a cost-effective treatment and should not be restricted for appropriate patients by payers looking to save money as demand for the procedure increases, said Dr. Joshua Jacobs, president of the American Academy of Orthopaedic Surgeons.

This rise in demand is driven by the fact that total knee arthroplasty for end-stage osteoarthritis is one of the most successful surgical interventions and allows patients with chronic pain to return to work and normal recreational activities, Jacobs explained. The aging population will continue to drive demand with the total number of procedures forecasted to surpass three million by 2030 in the U.S.



Bloomberg BRIEF Newsletters